Smith & Nephew PLC

Latest Smith & Nephew PLC News and Updates

  • uploads///acquisitions
    Company & Industry Overviews

    Stryker’s Inorganic Growth Strategy Continues to Boost Growth

    Stryker’s acquisition-driven growth strategy Stryker (SYK) has been growing at a fast pace through inorganic growth. It has undertaken a number of strategic acquisitions recently. In 3Q17, acquisitions contributed approximately 0.6% of the company’s YoY (year-over-year) sales growth, and in the first three quarters of 2017, Stryker acquisitions contributed ~3.2% of the company’s sales growth […]

    By Sarah Collins
  • uploads///GLOBAL FOOTPRINTS
    Company & Industry Overviews

    Asia-Pacific Still Zimmer Biomet’s Strongest Geography

    Zimmer Biomet Holdings witnessed a strong performance in its Asia-Pacific region. It contributed 16% to the company’s total sales.

    By Sarah Collins
  • uploads///mako
    Earnings Report

    How Mako Robots Are Driving Stryker’s Sales in 2017

    Mako sales in 3Q17 In 3Q17, Stryker sold 33 Mako robots, compared with 30 robots in 3Q16. In 2Q17, Stryker installed 26 Mako robots. Of these 33 robots, 23 were installed in the United States. Around 40% of US sales are expected to be in competitive accounts. Stryker is training surgeons on its total knee application […]

    By Sarah Collins
  • uploads///knee market share
    Company & Industry Overviews

    ZBH’s Persona Partial Knee Launch Expands Knee Implant Portfolio

    On September 11, 2017, Zimmer Biomet Holdings (ZBH) announced the launch of its Persona Partial Knee System.

    By Sarah Collins
  • uploads///careadvantage
    Company & Industry Overviews

    Inside the Latest Capability Advancement in Johnson & Johnson’s Orthopedics

    On January 9, JNJ’s Medical Device division announced its Orthopedic Episode of Care Approach, a data-driven program that will accelerate value-based care.

    By Sarah Collins
  • uploads///MITG
    Earnings Report

    Here’s What’s Driving Medtronic’s MITG Segment

    Of Medtronic’s ~$7.3 billion in worldwide revenues in fiscal 2Q17, ~$2.5 billion came from Medtronic’s MITG segment, representing ~34% of the company’s total revenues.

    By Sarah Collins
  • uploads///Portfolio Breakdown of the PRITX
    Consumer

    A Look at PRITX’s Portfolio Changes So Far in 2016

    PRITX aims to invest in established companies that are either headquartered outside of the United States or whose main businesses are carried out outside the United States.

    By David Ashworth
  • uploads///stryker sales mix
    Company & Industry Overviews

    How Stryker Plans to Leverage the Under-Tapped Europe Opportunity

    Europe represents a potential growth opportunity for Stryker, as the company currently has a low market share in Europe compared to other developed markets.

    By Sarah Collins
  • uploads///integration
    Company & Industry Overviews

    Zimmer Biomet’s Realized Synergies, Market Position after Integration

    Zimmer Holdings acquired Biomet in June 2015 and formed Zimmer Biomet Holdings (ZBH). The acquisition established the combined company as the second-largest player in the orthopedics medical device market segment.

    By Sarah Collins
  • uploads///Portfolio Breakdown of the BIAHX
    Fund Managers

    Seeking Returns by Investing Mainly in European Equity Securities

    The Brown Advisory WMC Strategic European Equity Fund Investor Shares generally invests at least 80% of its net assets in European companies.

    By David Ashworth
  • Company & Industry Overviews

    Industrials and Discretionary Helped AEDAX in 1Q16

    AEDAX fell 0.9% in 1Q16. But it still ranked second best among the 12 funds in this review.

    By David Ashworth
  • uploads///KNEE MARKET SHARE
    Company & Industry Overviews

    Zimmer Biomet Faces Market Share Erosion in the Knee Implant Market

    Zimmer Biomet (ZBH) is the leading provider of knee implants in the United States. It has approximately 40% market share, followed by Stryker, Johnson & Johnson, and Smith & Nephew.

    By Sarah Collins
  • Company & Industry Overviews

    Solid Metrics Make BIAHX Less Volatile Than Peers

    From a NAV return standpoint, BIAHX stood third among its peers for the one-year period until March 15, 2016. Since the ECB announcement of stimulus measures, the fund is fifth.

    By David Ashworth
  • Company & Industry Overviews

    BIAHX: Could It Be a Candidate for Your Shortlist?

    The Brown Advisory – WMC Strategic European Equity Fund (BIAHX) was managing assets worth $1.1 billion as of January 2016.

    By David Ashworth
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.